Press Releases
Teva Announces Launch of Generic Epzicom® Tablets in the United States
Teva Pharmaceutical Industries Ltd announced the launch of a generic equivalent of Epzicom®1 (abacavir and lamivudine) tablets, 600 mg/300 mg, in the United States...
Clinical Trials
Genocea’s Immunotherapy GEN-003 Demonstrates Significant Reduction of Viral Shedding in Phase 2b Clinical Trial
Genocea Biosciences, a biopharmaceutical company developing T cell-directed vaccines and immunotherapies announced positive results from its ongoing Phase 2b trial evaluating a new Phase...
Drug Research
Amgen And Arrowhead Pharmaceuticals Announce Two Cardiovascular Collaborations
Amgen and Arrowhead Pharmaceuticals Inc announced two license and collaboration agreements to develop and commercialize RNA interference (RNAi) therapies for cardiovascular disease. ...
Clinical Trials
Threshold Announces Interim Results from Tarloxotinib Program and its Plans to Focus on Evofosfamide and Earlier-Stage Opportunities
Threshold Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company specializing in the development of novel pharmaceutical products and technologies for the treatment of cancer, announced interim...
Drug Research
Boehringer Ingelheim boosts immune-oncology pipeline through collaboration with viratherapeutics
Boehringer Ingelheim and ViraTherapeutics announced a long term collaboration to jointly develop a next generation oncolytic virus therapy platform and to investigate Vira Therapeutic’s...
Press Releases
Gilead Sciences and the World Health Organization Announce Five-Year Visceral Leishmaniasis Collaboration
Gilead Sciences Inc announced it has entered into a partnership with the World Health Organization (WHO) to provide $20 million in funding and drug...
Industry Reports
Pfizer Completes Acquisition of Medivation Inc
Pfizer Inc announced the successful completion of its acquisition of Medivation, Inc . As of the tender offer expiration, 115,574,041 shares of Medivation common...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read